Cts CTS

NYSE CTS

$56.11 -0.62 (-1.09%)

As of: Sep 9, 2026 · 11:45 AM EDT

Key Stats

Market Cap1.60 Bn

P/E22.98

P/S2.84

Div. Yield0.00

Total Debt (Qtr)55.00 Mn

Revenue Growth (1y) (Qtr)7.00

Add ratio to table…

About

CTS Corporation is a global manufacturer of sensors connectivity components and actuators. The company was established in 1896 as a provider of high-quality telephone products and was incorporated as an Indiana corporation in February 1929. Its principal executive offices are located in Lisle Illinois. CTS Corporation designs manufactures and sells a broad line of sensors connectivity components and actuators primarily to original equipment manufacturers tier one suppliers for the aerospace and defense industrial medical transportation markets and the U. S. Government. The company’s vision is to be a leading provider of sensing and motion devices as well as connectivity components enabling an intelligent and seamless world. These devices are categorized by their ability to Sense Connect or Move. Sense products provide vital inputs to electronic systems. Connect products allow systems to function in synchronization with other systems. Move products ensure required movements are effectively and accurately executed. CTS Corporation is committed to achieving its vision by continuing to invest in the development of products technologies and talent within these categories. It operates manufacturing facilities in North America Asia and Europe. Sales and marketing are accomplished through its sales engineers independent manufacturers representatives and distributors.

CTS Corporation generates revenue primarily from the sale of its sensors connectivity components and actuators to original equipment manufacturers tier one suppliers distributors and the U. S. Government. Products are grouped into Sense Connect and Move families. The Sense family includes controls pedals piezo sensing products sensors switches transducers. The Connect family includes EMI/RFI filters capacitors frequency control products resistors RF filters. The Move family includes piezo microactuators rotary actuators. In 2025 transportation accounted for 43 percent of net sales industrial 26 percent medical 16 percent and aerospace and defense 15 percent. Revenue is also derived through its sales engineers independent manufacturers representatives and distributors with approximately 86 percent of 2025 net sales attributable to sales engineers 7 percent to independent distributors and 7 percent to independent manufacturers representatives.

CTS Corporation competes with domestic and foreign manufacturers on product features technology price quality reliability delivery and service. Most product lines encounter competition globally with the number of competitors varying across lines. No single competitor competes with the company in every product line but some competitors are larger and more diversified. The company believes it competes most successfully in custom engineered products manufactured to meet specific applications of major OEMs. Additionally the company faces risks of technical obsolescence and pressure from customers seeking lower cost and higher quality reliability and delivery standards.

The company’s customer base includes original equipment manufacturers tier one suppliers distributors and the U. S. Government. Significant customers in 2025 were Toyota Motor Corporation representing 11.2 percent of total net sales and Cummins Inc representing 8.4 percent. No other customer accounted for ten percent or more of total net sales in those years. CTS Corporation also works with global and regional distributors such as Avnet Inc Digi-Key Electronics Master Electronics Future Electronics and TTI Inc. It serves aerospace and defense industrial medical transportation markets and government agencies.

Investment Thesis

▲ Bull case

CTS Corporation's medical end market demonstrates exceptional growth potential driven by sustained demand in therapeutic applications and capacity expansion ahead of demand, with first-quarter sales up 28% year-over-year and bookings up 18%, reflecting a book-to-bill ratio of 1.2 that signals ongoing momentum. The company has secured multiple wins in medical ultrasound and a large contract for noninvasive aesthetics, supported by strong customer partnerships that allow for proactive capacity installation, positioning CTS to capitalize on aging population trends and healthcare innovation without supply constraints. This segment's superior margin profile, as acknowledged by management, directly contributes to improved earnings quality and provides a resilient foundation for overall profitability as diversified markets continue to outperform transportation. The strategic focus on mission-critical applications like diagnostics and patient monitoring ensures long-term relevance and pricing power, reducing vulnerability to cyclical downturns in other sectors.
CTS's aerospace and defense segment, despite flat bookings in Q1, possesses a robust pipeline and significant backlog opportunities, including a recently awarded underwater hull penetrator contract with a potential five-year value of $20 million and multiple wins in naval sonar and secure communications, indicating deepening customer relationships and future revenue visibility. Management expects defense bookings to normalize in the second half of 2026 as government funding cycles improve with the enactment of the full-year appropriations bill, and the lumpiness inherent in defense ordering patterns suggests current underperformance is temporary rather than structural. The company's RF and EMC filters, piezoelectric sensors, and transducers are mission-critical for modern undersea warfare, radar, and unmanned systems, aligning with elevated defense spending driven by geopolitical unrest and naval infrastructure investments, which should drive sustained demand beyond near-term funding delays.
Industrial end market strength, with Q1 sales up 14% year-over-year and bookings up 28%, reflects a broader recovery supported by secular tailwinds in automation, connectivity, digitization, and energy efficiency, where CTS's temperature sensing wins in heat pumps, pool and spa systems, and commercial appliances directly enable optimized industrial performance. The book-to-bill ratio of 1.29, up from 1.15 in 2025, confirms accelerating demand from both OEM and distribution channels, and the company's success across diverse applications like industrial printing and flow metering demonstrates broad-based adoption of its advanced sensing technologies. This segment benefits from long-term structural shifts rather than temporary rebounds, as manufacturing automation and efficiency initiatives continue to expand the addressable market for precision sensors and transducers, reducing reliance on volatile end markets like transportation.
CTS's transportation segment, while showing only 3% Q1 sales growth, exhibits early signs of stabilization with 7% sequential quarter-over-quarter growth and new business wins in current sensing for European OEMs and foot controls across China, Japan, Europe, and North America, indicating successful diversification within the vehicle architecture. The qualification of next-generation smart actuators and addition of accelerometers for ADAS and safety applications position CTS to benefit from long-term trends in vehicle electrification, software control, and electronic braking, where its powertrain-agnostic solutions deliver meaningful cost and weight advantages critical for OEMs managing performance and affordability trade-offs. With commercial vehicle demand expected to improve in the second half of 2026 due to rising freight rates and pre-buy activity ahead of EPA 2027 emission regulations, the transportation segment is poised for a meaningful inflection point that could drive accelerated growth beyond current expectations.

CTS Corporation's medical end market demonstrates exceptional growth potential driven by sustained demand in therapeutic applications and capacity expansion ahead of demand, with first-quarter sales up 28% year-over-year and bookings up 18%, reflecting a book-to-bill ratio of 1.2 that signals ongoing momentum. The company has secured multiple wins in medical ultrasound and a large contract for noninvasive aesthetics, supported by strong customer partnerships that allow for proactive capacity installation, positioning CTS to capitalize on aging population trends and healthcare innovation without supply constraints. This segment's superior margin profile, as acknowledged by management, directly contributes to improved earnings quality and provides a resilient foundation for overall profitability as diversified markets continue to outperform transportation. The strategic focus on mission-critical applications like diagnostics and patient monitoring ensures long-term relevance and pricing power, reducing vulnerability to cyclical downturns in other sectors.
CTS's aerospace and defense segment, despite flat bookings in Q1, possesses a robust pipeline and significant backlog opportunities, including a recently awarded underwater hull penetrator contract with a potential five-year value of $20 million and multiple wins in naval sonar and secure communications, indicating deepening customer relationships and future revenue visibility. Management expects defense bookings to normalize in the second half of 2026 as government funding cycles improve with the enactment of the full-year appropriations bill, and the lumpiness inherent in defense ordering patterns suggests current underperformance is temporary rather than structural. The company's RF and EMC filters, piezoelectric sensors, and transducers are mission-critical for modern undersea warfare, radar, and unmanned systems, aligning with elevated defense spending driven by geopolitical unrest and naval infrastructure investments, which should drive sustained demand beyond near-term funding delays.
Industrial end market strength, with Q1 sales up 14% year-over-year and bookings up 28%, reflects a broader recovery supported by secular tailwinds in automation, connectivity, digitization, and energy efficiency, where CTS's temperature sensing wins in heat pumps, pool and spa systems, and commercial appliances directly enable optimized industrial performance. The book-to-bill ratio of 1.29, up from 1.15 in 2025, confirms accelerating demand from both OEM and distribution channels, and the company's success across diverse applications like industrial printing and flow metering demonstrates broad-based adoption of its advanced sensing technologies. This segment benefits from long-term structural shifts rather than temporary rebounds, as manufacturing automation and efficiency initiatives continue to expand the addressable market for precision sensors and transducers, reducing reliance on volatile end markets like transportation.
CTS's transportation segment, while showing only 3% Q1 sales growth, exhibits early signs of stabilization with 7% sequential quarter-over-quarter growth and new business wins in current sensing for European OEMs and foot controls across China, Japan, Europe, and North America, indicating successful diversification within the vehicle architecture. The qualification of next-generation smart actuators and addition of accelerometers for ADAS and safety applications position CTS to benefit from long-term trends in vehicle electrification, software control, and electronic braking, where its powertrain-agnostic solutions deliver meaningful cost and weight advantages critical for OEMs managing performance and affordability trade-offs. With commercial vehicle demand expected to improve in the second half of 2026 due to rising freight rates and pre-buy activity ahead of EPA 2027 emission regulations, the transportation segment is poised for a meaningful inflection point that could drive accelerated growth beyond current expectations.

▼ Bear case

CTS Corporation's gross margin expansion of 250 basis points in Q1 2026, while impressive, may not be sustainable due to mounting cost pressures from precious metals inflation, oil-derived products like resin and epoxy, and transportation expenses, which management acknowledges are expected to intensify from late Q1 into Q2, with only partial mitigation through customer pricing adjustments and supplier collaboration. The favorable impact of foreign currency changes—contributing $3 million to sales and $700 thousand to gross margin—introduces volatility that could reverse if currency trends shift, and the company's reliance on timing differences to absorb cost pressures suggests margin stability is contingent on execution rather than structural advantage, leaving earnings vulnerable to external shocks beyond management's full control.
The aerospace and defense segment's dependency on unpredictable government funding cycles creates significant revenue lumpiness, as evidenced by a book-to-bill ratio below one in Q1 despite a strong pipeline, with recovery contingent on the enactment and disbursement of the full-year appropriations bill in February—a timeline subject to political delays that could defer revenue recognition into 2027, undermining near-term growth expectations. While management cites elevated defense spending due to geopolitical unrest, the segment's performance remains tethered to federal budget processes, and the potential for delayed appropriations or continuing resolutions introduces execution risk that could suppress bookings-to-sales conversion, particularly for large, complex contracts like the $20 million underwater hull penetrator win, which may not materialize as anticipated if funding streams remain fragmented.
Transportation segment growth remains highly sensitive to global light vehicle production volumes, which IHS forecasts show softening for 2026, with North American volumes expected in the 15 million unit range and European production forecasted between 16 to 17 million units—levels that reflect weakening demand rather than recovery—and although commercial vehicle strength is anticipated in the second half, it may not fully offset light vehicle weakness, especially if geopolitical tensions disrupt supply chains for petroleum products, rare earth metals, or semiconductors, which CTS explicitly monitors as potential headwinds. The company's reliance on Section 232 tariff adaptations and agility in cost management implies ongoing margin pressure in transportation, where modest 3% Q1 growth and a book-to-bill ratio of 1.1 suggest limited pricing power and vulnerability to OEM cost-cutting initiatives during periods of economic uncertainty.
Despite strong cash generation and a $91 million cash balance, CTS's increased borrowings of $63 million from its credit facility at Q1 end—driven by incentive compensation payments, share buybacks, and higher-than-expected CapEx—reflect a working capital strain that could limit financial flexibility if operating cash flow fails to scale with revenue growth, particularly as the company returned $10 million to shareholders via dividends and buybacks while maintaining only $82 million remaining under its repurchase program, suggesting that aggressive shareholder returns may come at the expense of liquidity buffers needed to navigate supply chain disruptions or sudden cost inflation in key input materials like precious metals and resin.

CTS Corporation's gross margin expansion of 250 basis points in Q1 2026, while impressive, may not be sustainable due to mounting cost pressures from precious metals inflation, oil-derived products like resin and epoxy, and transportation expenses, which management acknowledges are expected to intensify from late Q1 into Q2, with only partial mitigation through customer pricing adjustments and supplier collaboration. The favorable impact of foreign currency changes—contributing $3 million to sales and $700 thousand to gross margin—introduces volatility that could reverse if currency trends shift, and the company's reliance on timing differences to absorb cost pressures suggests margin stability is contingent on execution rather than structural advantage, leaving earnings vulnerable to external shocks beyond management's full control.
The aerospace and defense segment's dependency on unpredictable government funding cycles creates significant revenue lumpiness, as evidenced by a book-to-bill ratio below one in Q1 despite a strong pipeline, with recovery contingent on the enactment and disbursement of the full-year appropriations bill in February—a timeline subject to political delays that could defer revenue recognition into 2027, undermining near-term growth expectations. While management cites elevated defense spending due to geopolitical unrest, the segment's performance remains tethered to federal budget processes, and the potential for delayed appropriations or continuing resolutions introduces execution risk that could suppress bookings-to-sales conversion, particularly for large, complex contracts like the $20 million underwater hull penetrator win, which may not materialize as anticipated if funding streams remain fragmented.
Transportation segment growth remains highly sensitive to global light vehicle production volumes, which IHS forecasts show softening for 2026, with North American volumes expected in the 15 million unit range and European production forecasted between 16 to 17 million units—levels that reflect weakening demand rather than recovery—and although commercial vehicle strength is anticipated in the second half, it may not fully offset light vehicle weakness, especially if geopolitical tensions disrupt supply chains for petroleum products, rare earth metals, or semiconductors, which CTS explicitly monitors as potential headwinds. The company's reliance on Section 232 tariff adaptations and agility in cost management implies ongoing margin pressure in transportation, where modest 3% Q1 growth and a book-to-bill ratio of 1.1 suggest limited pricing power and vulnerability to OEM cost-cutting initiatives during periods of economic uncertainty.
Despite strong cash generation and a $91 million cash balance, CTS's increased borrowings of $63 million from its credit facility at Q1 end—driven by incentive compensation payments, share buybacks, and higher-than-expected CapEx—reflect a working capital strain that could limit financial flexibility if operating cash flow fails to scale with revenue growth, particularly as the company returned $10 million to shareholders via dividends and buybacks while maintaining only $82 million remaining under its repurchase program, suggesting that aggressive shareholder returns may come at the expense of liquidity buffers needed to navigate supply chain disruptions or sudden cost inflation in key input materials like precious metals and resin.

Customer Breakdown of Revenue (2025)

Peer group

Peer Comparison

Companies in the Electrical Equipment

S.No.	Ticker	Company	match	Market Cap	P/E	P/S	Total Debt (Qtr)
1	APH	Amphenol Corp /De/	primary	200.90 Bn	38.73	6.92	18.81 Bn
2	ETN	Eaton Corp plc	primary	161.94 Bn	42.23	5.39	22.70 Bn
3	VRT	Vertiv Holdings Co	primary	103.13 Bn	59.54	8.98	2.94 Bn
4	TEL	TE Connectivity plc	primary	59.70 Bn	19.34	3.09	5.63 Bn
5	NVT	nVent Electric plc	primary	25.98 Bn	43.42	5.37	1.51 Bn
6	HUBB	Hubbell Inc	primary	24.15 Bn	26.63	3.88	5.37 Bn
7	AEIS	Advanced Energy Industries Inc	primary	11.25 Bn	43.66	5.52	1.26 Bn
8	APTV	Aptiv PLC	primary	9.48 Bn	33.86	0.51	5.38 Bn

Cts CTS

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Customer Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password